Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Seagen Inc. (SGEN : NSDQ)
 
 • Company Description   
Seagen Inc. is a biotechnology company. It discovers, develops and commercializes transformative cancer medicines. The company operates principally in California, Canada, Switzerland and the European Union. Seagen Inc., formerly known as Seattle Genetics Inc., is headquartered in the Seattle.

Number of Employees: 2,675

 
 • Price / Volume Information   
Yesterday's Closing Price: $142.54 Daily Weekly Monthly
20 Day Moving Average: 1,245,412 shares
Shares Outstanding: 184.08 (millions)
Market Capitalization: $26,238.14 (millions)
Beta: 0.85
52 Week High: $192.79
52 Week Low: $105.43
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -1.28% 8.17%
12 Week 18.53% 28.61%
Year To Date -7.80% 9.64%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
21823 30TH DRIVE SE SUITE
-
BOTHELL,WA 98021
USA
ph: 425-527-4000
fax: 425-527-4001
investors@seagen.com http://www.seagen.com
 
 • General Corporate Information   
Officers
Clay B. Siegall - Chief Executive Officer; President and director
Todd E. Simpson - ChiefFinancialOfficer
Felix J. Baker - Director
David W. Gryska - Director
Marc E. Lippman - Director

Peer Information
Seagen Inc. (CORR.)
Seagen Inc. (RSPI)
Seagen Inc. (CGXP)
Seagen Inc. (BGEN)
Seagen Inc. (GTBP)
Seagen Inc. (RGRX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 81181C104
SIC: 2836
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
Share - Related Items
Shares Outstanding: 184.08
Most Recent Split Date: (:1)
Beta: 0.85
Market Capitalization: $26,238.14 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.82 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-3.51 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 9.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 16.84% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 8.75
Price/Cash Flow: -
Price / Sales: 15.72
EPS Growth
vs. Year Ago Period: -10.45%
vs. Previous Quarter: 22.11%
Sales Growth
vs. Year Ago Period: 28.46%
vs. Previous Quarter: -0.79%
ROE
03/31/22 - -21.86
12/31/21 - -20.68
09/30/21 - -9.88
ROA
03/31/22 - -18.07
12/31/21 - -17.30
09/30/21 - -8.38
Current Ratio
03/31/22 - 5.22
12/31/21 - 5.04
09/30/21 - 4.46
Quick Ratio
03/31/22 - 4.70
12/31/21 - 4.69
09/30/21 - 4.20
Operating Margin
03/31/22 - -41.32
12/31/21 - -42.84
09/30/21 - -19.06
Net Margin
03/31/22 - -41.32
12/31/21 - -42.84
09/30/21 - -19.06
Pre-Tax Margin
03/31/22 - -41.32
12/31/21 - -42.92
09/30/21 - -19.07
Book Value
03/31/22 - 16.29
12/31/21 - 16.76
09/30/21 - 17.31
Inventory Turnover
03/31/22 - 1.63
12/31/21 - 1.80
09/30/21 - 1.89
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©